Can you please clarify who holds the largest share of ownership in CRISPR Therapeutics, the pioneering gene-editing company? Are we referring to an individual investor, a venture capital firm, or perhaps a pharmaceutical giant that has taken a significant stake in the company? Additionally, is there any recent news or developments that have led to changes in the company's shareholder composition, and how might these changes impact the company's overall strategy and performance?
5 answers
SsamziegangStroll
Mon Aug 12 2024
Among the prominent shareholders is ARK Investment Management LLC, a renowned investment firm known for its innovative strategies and focus on disruptive technologies.
MysticEchoFirefly
Mon Aug 12 2024
Capital International Investors, another major player, brings its extensive experience and global network to the table, contributing to the overall strength of the shareholder base.
KpopStarlet
Mon Aug 12 2024
The ARKK - ARK Innovation ETF, a popular exchange-traded fund, also holds a notable stake, reflecting the growing interest in innovative technologies and businesses among investors.
Lorenzo
Mon Aug 12 2024
The cumulative ownership of shares by these institutions stands at a significant figure of 75,331,220, highlighting their substantial influence in the market.
Stefano
Mon Aug 12 2024
BTCC, a UK-based cryptocurrency exchange, offers a comprehensive suite of services including spot trading, futures contracts, and secure wallets, catering to the diverse needs of the digital asset community. Its inclusion among the shareholders further underscores the intersection of traditional finance and the emerging crypto market.